These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 7653818)

  • 1. A clinical and pharmacokinetic comparison of ropivacaine and bupivacaine in axillary plexus block.
    Vainionpää VA; Haavisto ET; Huha TM; Korpi KJ; Nuutinen LS; Hollmén AI; Jozwiak HM; Magnusson AA
    Anesth Analg; 1995 Sep; 81(3):534-8. PubMed ID: 7653818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and efficacy of 40 ml ropivacaine 7.5 mg/ml (300 mg), for axillary brachial plexus block--an open pilot study.
    Wank W; Büttner J; Maier KR; Emanuelson BM; Selander D
    Eur J Drug Metab Pharmacokinet; 2002; 27(1):53-9. PubMed ID: 11996328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of 0.5% ropivacaine and 0.5% bupivacaine for axillary brachial plexus anaesthesia.
    McGlade DP; Kalpokas MV; Mooney PH; Chamley D; Mark AH; Torda TA
    Anaesth Intensive Care; 1998 Oct; 26(5):515-20. PubMed ID: 9807606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of three doses of epidural ropivacaine during hysterectomy and comparison with bupivacaine.
    Sandler AN; Arlander E; Finucane BT; Taddio A; Chan V; Milner A; Callahan-Enright SO; Friedlander M; Muzyka D
    Can J Anaesth; 1998 Sep; 45(9):843-9. PubMed ID: 9818106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of 0.25% ropivacaine and 0.25% bupivacaine for brachial plexus block.
    Hickey R; Rowley CL; Candido KD; Hoffman J; Ramamurthy S; Winnie AP
    Anesth Analg; 1992 Oct; 75(4):602-6. PubMed ID: 1530173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the pharmacodynamics and pharmacokinetics of bupivacaine, ropivacaine (with epinephrine) and their equal volume mixtures with lidocaine used for femoral and sciatic nerve blocks: a double-blind randomized study.
    Cuvillon P; Nouvellon E; Ripart J; Boyer JC; Dehour L; Mahamat A; L'hermite J; Boisson C; Vialles N; Lefrant JY; de La Coussaye JE
    Anesth Analg; 2009 Feb; 108(2):641-9. PubMed ID: 19151302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma concentrations of ropivacaine given with or without epinephrine for brachial plexus block.
    Hickey R; Blanchard J; Hoffman J; Sjovall J; Ramamurthy S
    Can J Anaesth; 1990 Nov; 37(8):878-82. PubMed ID: 2253294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 0.75% and 0.5% ropivacaine for axillary brachial plexus block: a clinical comparison with 0.5% bupivacaine.
    Bertini L; Tagariello V; Mancini S; Ciaschi A; Posteraro CM; Di Benedetto P; Martini O
    Reg Anesth Pain Med; 1999; 24(6):514-8. PubMed ID: 10588554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of ropivacaine 0.5% and bupivacaine 0.5% for brachial plexus block.
    Hickey R; Hoffman J; Ramamurthy S
    Anesthesiology; 1991 Apr; 74(4):639-42. PubMed ID: 2008942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of 0.2% ropivacaine and 0.2% bupivacaine following caudal blocks in children.
    Ala-Kokko TI; Partanen A; Karinen J; Kiviluoma K; Alahuhta S
    Acta Anaesthesiol Scand; 2000 Oct; 44(9):1099-102. PubMed ID: 11028730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Axillary brachial plexus block with ropivacaine 7.5 mg/ml. A comparative study with bupivacaine 5 mg/ml.
    Raeder JC; Drøsdahl S; Klaastad O; Kvalsvik O; Isaksen B; Strømskag KE; Mowinckel P; Bergheim R; Selander D
    Acta Anaesthesiol Scand; 1999 Sep; 43(8):794-8. PubMed ID: 10492405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicentre trial of ropivacaine 7.5 mg x ml(-1) vs bupivacaine 5 mg x ml(-1) for supra clavicular brachial plexus anesthesia.
    Vaghadia H; Chan V; Ganapathy S; Lui A; McKenna J; Zimmer K
    Can J Anaesth; 1999 Oct; 46(10):946-51. PubMed ID: 10522581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose bupivacaine, levobupivacaine and ropivacaine in axillary brachial plexus block.
    Liisanantti O; Luukkonen J; Rosenberg PH
    Acta Anaesthesiol Scand; 2004 May; 48(5):601-6. PubMed ID: 15101856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of ropivacaine and bupivacaine for bilateral intercostal blockade in healthy male volunteers.
    Kopacz DJ; Emanuelsson BM; Thompson GE; Carpenter RL; Stephenson CA
    Anesthesiology; 1994 Nov; 81(5):1139-48. PubMed ID: 7978472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of ropivacaine 0.1% and 0.2% with bupivacaine 0.2% for single-shot caudal anaesthesia in children.
    Luz G; Innerhofer P; Häussler B; Oswald E; Salner E; Sparr H
    Paediatr Anaesth; 2000; 10(5):499-504. PubMed ID: 11012953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Comparison of Differences Between the Systemic Pharmacokinetics of Levobupivacaine and Ropivacaine During Continuous Epidural Infusion: A Prospective, Randomized, Multicenter, Double-Blind Controlled Trial.
    Perotti L; Cusato M; Ingelmo P; Niebel TL; Somaini M; Riva F; Tinelli C; De Andrés J; Fanelli G; Braschi A; Regazzi M; Allegri M
    Anesth Analg; 2015 Aug; 121(2):348-56. PubMed ID: 25977992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of ropivacaine in uremic and nonuremic patients after axillary brachial plexus block.
    Pere P; Salonen M; Jokinen M; Rosenberg PH; Neuvonen PJ; Haasio J
    Anesth Analg; 2003 Feb; 96(2):563-9, table of contents. PubMed ID: 12538213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of 0.75% ropivacaine and 0.5% bupivacaine after ilioinguinal-iliohypogastric nerve block in children.
    Ala-Kokko TI; Karinen J; Räihä E; Kiviluoma K; Alahuhta S
    Br J Anaesth; 2002 Sep; 89(3):438-41. PubMed ID: 12402722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interscalene brachial plexus anesthesia with ropivacaine 5 mg/mL and bupivacaine 5 mg/mL: effects on electrocardiogram.
    Borgeat A; Ekatodramis G; Blumenthal S
    Reg Anesth Pain Med; 2004; 29(6):557-63. PubMed ID: 15635515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical application of ropivacaine for the upper extremity.
    Singelyn FJ
    Curr Top Med Chem; 2001 Aug; 1(3):219-25. PubMed ID: 11895140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.